DOCSLIB.ORG

Chymase Α Inactivated Extracellularly By

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Chymase Α Inactivated Extracellularly By Mast Cell Tissue Inhibitor of Metalloproteinase-1 Is Cleaved and Inactivated Extracellularly by α-Chymase This information is current as Brendon T. Frank, J. Caleb Rossall, George H. Caughey and of September 24, 2021. Kenneth C. Fang J Immunol 2001; 166:2783-2792; ; doi: 10.4049/jimmunol.166.4.2783 http://www.jimmunol.org/content/166/4/2783 Downloaded from References This article cites 56 articles, 23 of which you can access for free at: http://www.jimmunol.org/content/166/4/2783.full#ref-list-1 http://www.jimmunol.org/ Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication by guest on September 24, 2021 *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2001 by The American Association of Immunologists All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. Mast Cell Tissue Inhibitor of Metalloproteinase-1 Is Cleaved and Inactivated Extracellularly by ␣-Chymase1 Brendon T. Frank,* J. Caleb Rossall,* George H. Caughey,*† and Kenneth C. Fang2*† We previously reported that mast cell ␣-chymase cleaves and activates progelatinase B (progel B). Outside of cells, progel B is complexed with tissue inhibitor of metalloproteinase (TIMP)-1, which hinders zymogen activation and inhibits activity of mature forms. The current work demonstrates that dog BR mastocytoma cells, HMC-1 cells, and murine bone marrow-derived mast cells secrete TIMP-1 whose electrophoretic profile in supernatants suggests degranulation-dependent proteolysis. ␣-Chymase cleaves uncomplexed TIMP-1, reducing its ability to inhibit gel B, whereas tryptase has no effect. Sequencing of TIMP-1’s ␣-chymase- mediated cleavage products reveals hydrolysis at Phe12-Cys13 and Phe23-Val24 in loop 1 and Phe101-Val102 and Trp105-Asn106 in loop 3 of the NH2-terminal domain. TIMP-1 in a ternary complex with progel B and neutrophil gelatinase-associated lipocalin is ␣ ␣ also susceptible to -chymase cleavage, yielding products like those resulting from processing of free TIMP-1. Thus, -chymase Downloaded from cleaves free and gel B-bound TIMP-1. Incubation of the progel B-TIMP-1-neutrophil gelatinase-associated lipocalin complex with ␣-chymase increases gel B activity 2- to 5-fold, suggesting that ␣-chymase activates progel B whether it exists as free monomer or as a complex with TIMP-1. Furthermore, inhibition of ␣-chymase blocks degranulation-induced TIMP-1 processing (absent in ␣-chymase-deficient HMC-1 cells). Purified ␣-chymase processes TIMP-1 in BR supernatants, generating products like those induced by degranulation. In summary, these results suggest that controlled exocytosis of mast cell ␣-chymase activates progel B even in the presence of TIMP-1. This is the first identification of a protease that overcomes inhibition by bound TIMP-1 to activate http://www.jimmunol.org/ progel B without involvement of other proteases. The Journal of Immunology, 2001, 166: 2783–2792. ctivated mast cells respond to allergen, tumor invasion, inhibitors of metalloproteinases (TIMPs). Proteolytic activation of and fibrogenic injury by releasing tryptase and ␣-chy- pro-MMPs involves one or more activator proteases which remove A mase, which are granule-associated tryptic and chymo- the propeptide domain containing a critical Cys residue, thus dis- tryptic serine proteases, respectively. Upon degranulation, both rupting the cysteine switch which confers active site latency (9). proteases participate in proteolytic and nonproteolytic pathways TIMPs inhibit activity of active MMP species and block activation regulating matrix protein degradation, receptor activation, peptide of pro-MMPs by forming TIMP-MMP complexes in a 1:1 molar inactivation, and fibroblast, smooth muscle, or epithelial cell mi- by guest on September 24, 2021 ratio. NH2-terminal TIMP domains occupy the MMP active site togenesis (1). Tryptase and ␣-chymase may also act in a broader and COOH-terminal domains confer binding specificity through range of homeostatic and pathologic tissue remodeling processes interactions with COOH-terminal MMP domains (10). 2ϩ 2ϩ via interactions with a family of Ca - and Zn -dependent matrix Mast cells may regulate local MMP activity by contributing zy- 3 metalloproteinases (MMPs) (2–7). Secreted or cell surface-asso- mogen-activating serine proteases and by secreting pro-MMPs. ciated membrane-type MMPs participate in physiologic pathways Our previous work demonstrates that mast cells secrete progelati- such as embryonic development, organ morphogenesis, angiogen- nase B (progel B; MMP-9), which is activated extracellularly by esis, and wound healing, and also contribute to the pathogenesis of degranulated ␣-chymase upon cleavage of the catalytic domain at arthritis, cancer, cardiovascular disease, and lung fibrosis (8). Post- two sites (2–4). ␣-Chymase-dependent activation of progel B in translational regulation of MMP activity depends upon conversion vivo is hypothesized to switch nonangiogeneic tissues to an an- of proenzymes to mature active forms and their inhibition by tissue giogenic phenotype in premalignant lesions in a murine model of epithelial carcinogenesis (11). In addition to progel B, ␣-chymase also directly cleaves and activates procollagenase (MMP-1) and *Cardiovascular Research Institute and †Department of Medicine, University of Cal- ifornia, San Francisco, CA 94143 prostromelysin (MMP-3) (6, 7). Mast cells also express these two Received for publication October 4, 2000. Accepted for publication December MMPs plus progelatinase A (MMP-2), which shares in vitro sub- 7, 2000. strate specificity with gelatinase B (gel B) (4, 12, 13). The costs of publication of this article were defrayed in part by the payment of page Since cells secrete pro-MMPs bound to TIMPs in a complex, charges. This article must therefore be hereby marked advertisement in accordance zymogen activation likely requires prior TIMP processing which with 18 U.S.C. Section 1734 solely to indicate this fact. precedes proteolytic activation of the MMP moiety. TIMP-1 binds 1 This work was supported by Grants HL-03345 and HL-24136 from the National Institutes of Health. K.C.F. is the recipient of a Mentored Clinical Scientist Devel- to progel B, which is secreted as a monomer or dimer, or in di- opment Award from the National Institutes of Health. sulfide-mediated linkage with neutrophil gelatinase-associated li- 2 Address correspondence and reprint requests to Dr. Kenneth C. Fang, Box 0911, pocalin (NGAL) to form a ternary complex of progel B monomer, Cardiovascular Research Institute, University of California, San Francisco, CA TIMP-1 and NGAL (progel B-TIMP-1-NGAL) (14, 15). Unbound 94143-0911. E-mail address: [email protected] TIMP-1 may be inactivated in vitro by cleavage, degradation, or 3 Abbreviations used in this paper: MMP, matrix metalloproteinase; AAPF-CMK, Ala-Ala-Pro-Phe chloromethyl ketone; DNP-PGCHAK, DNP-Pro-Gly-Cys(Me)-His- chemical modification via proteolytic and nonproteolytic mecha- Ala-Lys(N-Me-Abz)-NH2; gel B, gelatinase B; HNE, human neutrophil elastase; KL, nisms involving serine or thiol proteases and reactive oxygen spe- recombinant canine kit ligand; MBMMC, murine bone marrow-derived mast cells; NGAL, neutrophil gelatinase-associated lipocalin; progel B, progelatinase B; TIMP, cies, respectively (16–19). However, mechanisms which regulate tissue inhibitor of metalloproteinase; rh, recombinant human. processing of MMP-bound TIMP-1 remain unclear. In addition to Copyright © 2001 by The American Association of Immunologists 0022-1767/01/$02.00 2784 ␣-CHYMASE CLEAVAGE OF TIMP-1 its ability to block pro-MMP activation and inhibit activity of ma- fore further analysis. To determine the electrophoretic profile of reaction ture MMPs, TIMP-1 also demonstrates erythroid-potentiating ac- products, aliquots were subjected to SDS-PAGE using 16% or 4–20% tivity, stimulates steroidogenesis, regulates mitogenesis, and con- gradient Tris-glycine gels (Invitrogen) under reducing conditions, with de- tection of proteins by Coomassie Blue R250 (Fisher Scientific, Tustin, CA) trols apoptosis via mechanisms which are independent of its MMP or immunoblotting using polyclonal rabbit anti-TIMP-1 or polyclonal rab- inhibitory activity (10). Thus, processing of TIMP-1 in the inflam- bit anti-MMP-9 Abs (Triple Point Biologics, Portland, OR). matory milieu may not only alter the protease:antiprotease balance TIMP-1 activity to favor proteolysis, but also attenuate or abolish its non-MMP inhibitory effects on specific cell populations. We report here that MMP inhibitory activity of rhTIMP-1 was determined by incubating intact ␣ mast cell ␣-chymase cleaves free TIMP-1 and processes the progel or -chymase-processed inhibitor with active gel B monomer (Calbio- chem). rhTIMP-1 was incubated alone or in the presence of various con- B-TIMP-1 complex by inactivating bound TIMP-1 and activating centrations of ␣-chymase in reaction buffer at 37°C for different time pe- progel B, without involvement of other
Load more

Recommended publications
  • Ige-Mediated Mast Cell Activation Promotes Inflammation And
    RESEARCH COMMUNICATION IgE-mediated mast cell activation promotes inflammation and cartilage destruction in osteoarthritis Qian Wang1,2†, Christin M Lepus1,2†, Harini Raghu1,2†, Laurent L Reber3‡, Mindy M Tsai3, Heidi H Wong1,2, Ericka von Kaeppler1,2, Nithya Lingampalli1,2, Michelle S Bloom1,2, Nick Hu1,2, Eileen E Elliott1,2, Francesca Oliviero4, Leonardo Punzi4, Nicholas J Giori1,5, Stuart B Goodman5, Constance R Chu1,5, Jeremy Sokolove1,2, Yoshihiro Fukuoka6, Lawrence B Schwartz6, Stephen J Galli3,7, William H Robinson1,2* 1GRECC, VA Palo Alto Health Care System, Palo Alto, United States; 2Division of Immunology and Rheumatology, Stanford University School of Medicine, Stanford, United States; 3Department of Pathology, Stanford University School of Medicine, Stanford, United States; 4Rheumatology Unit, Department of Medicine, University of Padova, Padova, Italy; 5Department of Orthopedic Surgery, Stanford University School of Medicine, Stanford, United States; 6Department of Internal Medicine, Virginia Commonwealth University School of Medicine, Richmond, United States; 7Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, United States *For correspondence: [email protected] Abstract Osteoarthritis is characterized by articular cartilage breakdown, and emerging †These authors contributed evidence suggests that dysregulated innate immunity is likely involved. Here, we performed equally to this work proteomic, transcriptomic, and electron microscopic analyses to demonstrate that mast cells are Present address: ‡Center for aberrantly activated in human and murine osteoarthritic joint tissues. Using genetic models of mast Physiopathology of Toulouse- cell deficiency, we demonstrate that lack of mast cells attenuates osteoarthritis in mice. Using Purpan (CPTP), UMR 1043, genetic and pharmacologic approaches, we show that the IgE/FceRI/Syk signaling axis is critical for University of Toulouse, INSERM, the development of osteoarthritis.
    [Show full text]
  • Biological Function of Mast Cell Chymase
    Biological Function of Mast Cell Chymase In vitro and in vivo studies: a thorny pathway Elena Chugunova Department of Molecular Biosciences Uppsala Doctoral thesis Swedish University of Agricultural Sciences Uppsala 2004 Acta Universitatis Agriculturae Sueciae Veterinaria 181 ISSN 1401-6257 ISBN 91-576-6680-6 © 2004 Elena Chugunova, Uppsala Tryck: SLU Service/Repro, Uppsala 2004 Abstract Chugunova, E., 2004. Biological function of mast cell chymase mMCP-4. In vitro and in vivo studies: a thorny pathway. Doctor's dissertation. ISSN 1401-6257, ISBN 91-576-6680-6 Mast cells (MCs) are key effector cells in various types of inflammatory conditions. The MC secretory granules contain inflammatory mediators such as histamine, heparin proteoglycan (PG), cytokines and various heparin-binding proteases, including tryptases, chymases and carboxypeptidase A. Previously, a mouse strain with a defect in its heparin biosynthesis was produced by targeting the gene for NDST-2 (N-deacetylase/N-sulfotransferase-2). These mice showed reduced levels of MC inflammatory mediators such as histamine and various heparin- binding proteases, including chymases, tryptases, and carboxypeptidase A. By using this mouse strain, we found that chymase in complex with heparin PG degraded fibronectin, suggesting a role for chymase in the regulation of connective tissue composition. Further, we found that chymase/heparin PG complexes degraded and thereby inactivated both thrombin and plasmin, suggesting an additional role for chymase in regulation of extravascular coagulation and fibrinolysis. However, although our findings implicated chymase in these processes, it was not possible to exclude the contribution to the observed activities by other MC components that are influenced by the knockout of NDST-2.
    [Show full text]
  • Extended Cleavage Specificities of Two Mast Cell Chymase-Related
    International Journal of Molecular Sciences Article Extended Cleavage Specificities of Two Mast Cell Chymase-Related Proteases and One Granzyme B-Like Protease from the Platypus, a Monotreme Zhirong Fu, Srinivas Akula , Michael Thorpe and Lars Hellman * Department of Cell and Molecular Biology, Uppsala University, Uppsala, The Biomedical Center, Box 596, SE-751 24 Uppsala, Sweden; [email protected] (Z.F.); [email protected] (S.A.); [email protected] (M.T.) * Correspondence: [email protected]; Tel.: +46-(0)18-471-4532; Fax: +46-(0)18-471-4862 Received: 20 November 2019; Accepted: 31 December 2019; Published: 2 January 2020 Abstract: Mast cells (MCs) are inflammatory cells primarily found in tissues in close contact with the external environment, such as the skin and the intestinal mucosa. They store large amounts of active components in cytoplasmic granules, ready for rapid release. The major protein content of these granules is proteases, which can account for up to 35 % of the total cellular protein. Depending on their primary cleavage specificity, they can generally be subdivided into chymases and tryptases. Here we present the extended cleavage specificities of two such proteases from the platypus. Both of them show an extended chymotrypsin-like specificity almost identical to other mammalian MC chymases. This suggests that MC chymotryptic enzymes have been conserved, both in structure and extended cleavage specificity, for more than 200 million years, indicating major functions in MC-dependent physiological processes. We have also studied a third closely related protease, originating from the same chymase locus whose cleavage specificity is closely related to the apoptosis-inducing protease from cytotoxic T cells, granzyme B.
    [Show full text]
  • Like Transmembrane Γ Evolved From
    Mast Cell α and β Tryptases Changed Rapidly during Primate Speciation and Evolved from γ-Like Transmembrane Peptidases in Ancestral Vertebrates This information is current as of September 25, 2021. Neil N. Trivedi, Qiao Tong, Kavita Raman, Vikash J. Bhagwandin and George H. Caughey J Immunol 2007; 179:6072-6079; ; doi: 10.4049/jimmunol.179.9.6072 http://www.jimmunol.org/content/179/9/6072 Downloaded from References This article cites 34 articles, 15 of which you can access for free at: http://www.jimmunol.org/content/179/9/6072.full#ref-list-1 http://www.jimmunol.org/ Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication by guest on September 25, 2021 *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2007 by The American Association of Immunologists All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology Mast Cell ␣ and ␤ Tryptases Changed Rapidly during Primate Speciation and Evolved from ␥-Like Transmembrane Peptidases in Ancestral Vertebrates1 Neil N. Trivedi, Qiao Tong, Kavita Raman, Vikash J. Bhagwandin, and George H.
    [Show full text]
  • Mast Cell Chymase and Kidney Disease
    International Journal of Molecular Sciences Review Mast Cell Chymase and Kidney Disease Shamila Vibhushan 1,2, Manuela Bratti 1,2 , Juan Eduardo Montero-Hernández 1,2 , Alaa El Ghoneimi 1,2,3, Marc Benhamou 1,2, Nicolas Charles 1,2 , Eric Daugas 1,2,4 and Ulrich Blank 1,2,* 1 Centre de Recherche sur l’inflammation, CNRS ERL8252, Faculté de Médecine site Bichat, Université de Paris, Inserm UMR1149, 16 rue Henri Huchard, F-75018 Paris, France; [email protected] (S.V.); [email protected] (M.B.); [email protected] (J.E.M.-H.); [email protected] (A.E.G.); [email protected] (M.B.); [email protected] (N.C.); [email protected] (E.D.) 2 Laboratoire d’Excellence Inflamex, Université de Paris, F-75018 Paris, France 3 Department of Pediatric Surgery and Urology, Hôpital Universitaire Robert Debré, Assistance Publique—Hôpitaux de Paris (APHP), F-75019 Paris, France 4 Service de Néphrologie, Groupe Hospitalier Universitaire Bichat-Claude Bernard, Assistance Publique—Hôpitaux de Paris (APHP), F-75019 Paris, France * Correspondence: [email protected] Abstract: A sizable part (~2%) of the human genome encodes for proteases. They are involved in many physiological processes, such as development, reproduction and inflammation, but also play a role in pathology. Mast cells (MC) contain a variety of MC specific proteases, the expression of which may differ between various MC subtypes. Amongst these proteases, chymase represents up to 25% of the total proteins in the MC and is released from cytoplasmic granules upon activation.
    [Show full text]
  • Correlation of Serpin–Protease Expression by Comparative Analysis of Real-Time PCR Profiling Data
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector Genomics 88 (2006) 173–184 www.elsevier.com/locate/ygeno Correlation of serpin–protease expression by comparative analysis of real-time PCR profiling data Sunita Badola a, Heidi Spurling a, Keith Robison a, Eric R. Fedyk a, Gary A. Silverman b, ⁎ Jochen Strayle c, Rosana Kapeller a,1, Christopher A. Tsu a, a Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, MA 02139, USA b Department of Pediatrics, University of Pittsburgh School of Medicine, Magee-Women’s Hospital, 300 Halket Street, Pittsburgh, PA 15213, USA c Bayer HealthCare AG, 42096 Wuppertal, Germany Received 2 December 2005; accepted 27 March 2006 Available online 18 May 2006 Abstract Imbalanced protease activity has long been recognized in the progression of disease states such as cancer and inflammation. Serpins, the largest family of endogenous protease inhibitors, target a wide variety of serine and cysteine proteases and play a role in a number of physiological and pathological states. The expression profiles of 20 serpins and 105 serine and cysteine proteases were determined across a panel of normal and diseased human tissues. In general, expression of serpins was highly restricted in both normal and diseased tissues, suggesting defined physiological roles for these protease inhibitors. A high correlation in expression for a particular serpin–protease pair in healthy tissues was often predictive of a biological interaction. The most striking finding was the dramatic change observed in the regulation of expression between proteases and their cognate inhibitors in diseased tissues.
    [Show full text]
  • TPSAB1 Monoclonal Antibody (AA1)
    Website: thermofisher.com Lot Number: SB2348992 Customer Service(US): 1 800 955 6288 ext. 1 Technical Support (US): 1 800 955 6288 ext. 441 thermofisher.com/contactus TPSAB1 Monoclonal Antibody (AA1) Catalog Number:MA5-11711 Product Data Sheet Details Species Reactivity Size 500 µL Canine, Feline, Human, Tested species reactivity Non-human primate Host / Isotype Mouse / IgG1 Published Species Reactivity Human, Mouse, Rat Class Monoclonal Type Antibody Tested Applications Dilution * Clone AA1 Western Blot (WB) 1:50 Human mast cell tryptase Immunohistochemistry (Paraffin) Immunogen 1:2000 purified from human lung tissues (IHC (P)) Form Liquid Published Applications Concentration 50µg/ml Immunocytochemistry (ICC) See 1 publications below Purification Protein G Immunohistochemistry (IHC) See 16 publications below Storage Buffer PBS, pH 7.4, with 0.2% BSA * Suggested working dilutions are given as a guide only. It is recommended that the user titrate the product for use in their own experiment using appropriate negative and positive controls. Contains 0.09% sodium azide Storage Conditions 4° C Product Specific Information MA5-11711 targets Mast Cell Tryptase in IHC (P) and WB applications and shows reactivity with Canine, Feline, Human, and Non-human primate samples. The MA5-11711 immunogen is human mast cell tryptase purified from human lung tissues. Background/Target Information Mast cells contain a number of preformed chemical mediators such as histamine, chymase, carboxypeptidase and proteolytic tryptase. A substantial quantity of tryptase is estimated to be found in mast cells of skin and lung and suggestes this enzyme plays a major role in mast cell mediated events. In vitro studies indicate tryptase can cleave C3 to form C3a anaphylatoxin, inactivate fibrinogen as a coaguable substrate for thrombin and activate latent collagenase.
    [Show full text]
  • Gene Expression Profiling of Human Mast Cell Subtypes
    Allergology International. 2006;55:173-179 ORIGINAL ARTICLE Gene Expression Profiling of Human Mast Cell Subtypes: An In Silico Study Hirohisa Saito1,2, Kenji Matsumoto1, Shigeru Okumura2, Jun-ichi Kashiwakura2, Keisuke Oboki2, Hidenori Yokoi2, Naotomo Kambe3, Ken Ohta4 and Yoshimichi Okayama2 ABSTRACT Background: Human mast cells (MCs) were classified into at least two subtypes, i.e., tryptase- and chymase- positive MCs (MCTC) and tryptase-only-positive MCs (MCT). However, differences in global molecular expres- sion between these subtypes are unknown. Methods: We analyzed public microarray data of MC subtypes derived from various tissues and those of pe- ripheral blood granulocytes by using hierarchical clustering methods to understand the global gene expression profiles. Results: All the transcripts subjected to this clustering analysis were classified into two large clusters, i.e., MC- preferential or granulocyte-preferential. In the original works, MCs from tonsil, lung and skin had been cultured for more than several weeks to obtain highly viable and pure cell populations, and these MCs retained their typical profiles such as intensities of chymase protein expression. Most of the transcripts were commonly ex- pressed by these MC subtypes. However, tonsil-derived MCs and skin-derived MCs but not lung-derived MCs expressed high levels of chymase (CMA1) as expected for the properties of MCTC and MCT. These CMA1-high MCs and CMA1-low MCs respectively expressed distinct sets of transcripts as small gene clusters as well as CMA-1 even after being cultured in the absence of a tissue environment. Conclusions: The MC lineage seems to be far from the granulocyte lineages including basophils.
    [Show full text]
  • A Genomic Analysis of Rat Proteases and Protease Inhibitors
    A genomic analysis of rat proteases and protease inhibitors Xose S. Puente and Carlos López-Otín Departamento de Bioquímica y Biología Molecular, Facultad de Medicina, Instituto Universitario de Oncología, Universidad de Oviedo, 33006-Oviedo, Spain Send correspondence to: Carlos López-Otín Departamento de Bioquímica y Biología Molecular Facultad de Medicina, Universidad de Oviedo 33006 Oviedo-SPAIN Tel. 34-985-104201; Fax: 34-985-103564 E-mail: [email protected] Proteases perform fundamental roles in multiple biological processes and are associated with a growing number of pathological conditions that involve abnormal or deficient functions of these enzymes. The availability of the rat genome sequence has opened the possibility to perform a global analysis of the complete protease repertoire or degradome of this model organism. The rat degradome consists of at least 626 proteases and homologs, which are distributed into five catalytic classes: 24 aspartic, 160 cysteine, 192 metallo, 221 serine, and 29 threonine proteases. Overall, this distribution is similar to that of the mouse degradome, but significatively more complex than that corresponding to the human degradome composed of 561 proteases and homologs. This increased complexity of the rat protease complement mainly derives from the expansion of several gene families including placental cathepsins, testases, kallikreins and hematopoietic serine proteases, involved in reproductive or immunological functions. These protease families have also evolved differently in the rat and mouse genomes and may contribute to explain some functional differences between these two closely related species. Likewise, genomic analysis of rat protease inhibitors has shown some differences with the mouse protease inhibitor complement and the marked expansion of families of cysteine and serine protease inhibitors in rat and mouse with respect to human.
    [Show full text]
  • Hereditary Alpha Tryptasemia, Mastocytosis and Beyond
    International Journal of Molecular Sciences Review Genetic Regulation of Tryptase Production and Clinical Impact: Hereditary Alpha Tryptasemia, Mastocytosis and Beyond Bettina Sprinzl 1,2, Georg Greiner 3,4,5 , Goekhan Uyanik 1,2,6, Michel Arock 7,8 , Torsten Haferlach 9, Wolfgang R. Sperr 4,10, Peter Valent 4,10 and Gregor Hoermann 4,9,* 1 Ludwig Boltzmann Institute for Hematology and Oncology at the Hanusch Hospital, Center for Medical Genetics, Hanusch Hospital, 1140 Vienna, Austria; [email protected] (B.S.); [email protected] (G.U.) 2 Center for Medical Genetics, Hanusch Hospital, 1140 Vienna, Austria 3 Department of Laboratory Medicine, Medical University of Vienna, 1090 Vienna, Austria; [email protected] 4 Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna, 1090 Vienna, Austria; [email protected] (W.R.S.); [email protected] (P.V.) 5 Ihr Labor, Medical Diagnostic Laboratories, 1220 Vienna, Austria 6 Medical School, Sigmund Freud Private University, 1020 Vienna, Austria 7 Department of Hematology, APHP, Pitié-Salpêtrière-Charles Foix University Hospital and Sorbonne University, 75013 Paris, France; [email protected] 8 Centre de Recherche des Cordeliers, INSERM, Sorbonne University, Cell Death and Drug Resistance in Hematological Disorders Team, 75006 Paris, France 9 MLL Munich Leukemia Laboratory, 81377 Munich, Germany; [email protected] 10 Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, 1090 Vienna, Austria * Correspondence: [email protected]; Tel.: +49-89-99017-315 Citation: Sprinzl, B.; Greiner, G.; Uyanik, G.; Arock, M.; Haferlach, T.; Abstract: Tryptase is a serine protease that is predominantly produced by tissue mast cells (MCs) and Sperr, W.R.; Valent, P.; Hoermann, G.
    [Show full text]
  • Sequence and Evolutionary Analysis of the Human Trypsin Subfamily of Serine Peptidases
    Biochimica et Biophysica Acta 1698 (2004) 77–86 www.bba-direct.com Sequence and evolutionary analysis of the human trypsin subfamily of serine peptidases George M. Yousefa,b, Marc B. Elliotta, Ari D. Kopolovica, Eman Serryc, Eleftherios P. Diamandisa,b,* a Department of Pathology and Laboratory Medicine, Division of Clinical Biochemistry, Mount Sinai Hospital, 600 University Avenue, Toronto, ON, Canada M5G 1X5 b Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada M5G 1L5 c Faculty of Medicine, Department of Medical Biochemistry, Menoufiya University, Egypt Received 3 June 2003; received in revised form 1 October 2003; accepted 27 October 2003 Abstract Serine peptidases (SP) are peptidases with a uniquely activated serine residue in the substrate-binding site. SP can be classified into clans with distinct evolutionary histories and each clan further subdivided into families. We analyzed 79 proteins representing the S1A subfamily of human SP, obtained from different databases. Multiple alignment identified 87 highly conserved amino acid residues. In most cases of substitution, a residue of similar character was inserted, implying that the overall character of the local region was conserved. We also identified several conserved protein motifs. 7–13 cysteine positions, potentially forming disulfide bridges, were also found to be conserved. Most members are secreted as inactive (pro) forms with a trypsin-like cleavage site for activation. Substrate specificity was predicted to be trypsin-like for most members, with few chymotrypsin-like proteins. Phylogenetic analysis enabled us to classify members of the S1A subfamily into structurally related groups; this might also help to functionally sort members of this subfamily and give an idea about their possible functions.
    [Show full text]
  • The Cystatin-Related Epididymal Spermatogenic Protein Inhibits the Serine Protease Prohormone Convertase 2
    0013-7227/03/$15.00/0 Endocrinology 144(3):901–908 Printed in U.S.A. Copyright © 2003 by The Endocrine Society doi: 10.1210/en.2002-220997 The Cystatin-Related Epididymal Spermatogenic Protein Inhibits the Serine Protease Prohormone Convertase 2 GAIL A. CORNWALL, ANGUS CAMERON, IRIS LINDBERG, DANIEL M. HARDY, NATHALY CORMIER, AND NELSON HSIA Department of Cell Biology and Biochemistry, Texas Tech University Health Sciences Center (G.A.C., D.M.H., N.C., N.H.), Lubbock, Texas 79430; Department of Biochemistry, University of Bristol (A.C.), Bristol, United Kingdom BS8 1TD; and Department of Biochemistry and Molecular Biology, Louisiana State University Health Sciences Center (I.L.), New Orleans, Louisiana 70112 The cystatin-related epididymal spermatogenic (CRES) pro- tase 2 (PC2), a protease involved in prohormone processing in tein is related to the family 2 cystatins of the cystatin super- the neuroendocrine system, whereas cystatin C showed no family of cysteine protease inhibitors. However, CRES lacks inhibition. CRES did not inhibit subtilisin, trypsin, or the sequences important for cysteine protease inhibitory activity convertase family members, PC1 and furin, indicating that it and is specifically expressed in reproductive and neuroendo- selectively inhibits PC2. Kinetic analysis showed that CRES is crine tissues. Thus, CRES is distinct from cystatins and may a competitive inhibitor of PC2 with a Ki of 25 nM. The removal perform unique tissue-specific functions. The purpose of the of N-terminal sequences from CRES decreased its affinity for present study was to determine whether CRES functions as a PC2, suggesting that the N terminus may be important for protease inhibitor in in vitro assays.
    [Show full text]